Evaluation of the efifcacy and safety of topical potent glucocorticoid combined with low or middle dose of systemic glucocorticoid in the treatment of patients with bullous pemphigoid

Muchi XU,Meng PAN,Haiqin ZHU,Weiping LI,Yafen YE,Jing XU,Jie ZHENG

2016-01-01

Abstract:Objective: To evaluate the efifcacy of topical potent glucocorticoid combined with low or middle dose of oral glucocorticoid in the treatment of patients with bullous pemphigoid (BP) and analyze the factors that inlfuence the outcome and prognosis.Methods: Fifty-four BP patients enrolled in this study were randomly divided into a control group receiving topical 0.05% halometasone propionate cream (15 ~ 60 g/d according to lesion area) and an observation group receiving topical glucocorticoid combined with oral prednisone [the dosage was 0.2 mg/(kg·d) for those with moderate disease or 0.4 mg/(kg·d) for those with extensive disease] based on the severity of their diseases (moderate or extensive). The daily newly appeared bullae, the days for disease controlled, the times for recurrence, adverse reactions and mortality rate were recorded and the correlation among peripheral blood eosinophil count and the levels of albumin and total immunoglobin E and clinical severity were analyzed, and furthermore, the related factors affecting the severity of disease and the efifcacy of therapy were evaluated.Results:The number of newly appeared bullae and eosinophil count were signiifcantly reduced in the control group after 3 week treatment and in the observation group after 2 or 3 week treatment. There was a positive correlation between the number of newly appeared bullae and eosinophil count in both groups and a negative correlation between the serum albumin level and the number of newly appeared bullae in the observation group. Disease control rate was signiifcantly higher in the observation group than the control group and recurrence rate was much lower in the observation group than the control group for the patients with mild to moderate disease. There were no significantly differences between two groups in the incidence of adverse event in the patients with different severity of disease.Conclusion:Topical glucocorticoid combined with low dose of oral glucocorticoid is effective for the treatment of BP and can fast control disease and decrease the relapse rate without a signiifcant increase of adverse reaction. There is a positive correlation between the peripheral blood eosinophil count and the clinical symptoms, which can be used as an observation indicator for efifcacy. High level of total immunoglobin E and low age are the risk factors for severity of BP.